Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Using early video capsule endoscopy for suspected upper gastrointestinal bleeding

Official title: A Randomized Controlled Trial Evaluating the Efficacy of Early Videocapsule Endoscopy Following Negative Gastroscopy in Patients Presenting With Suspected Upper Gastrointestinal Bleeding

Run by University of Alberta · NCT05108844 · Data updated 2026-11-12

This study is testing if using a tiny camera to look inside the gut right after a negative gastroscopy can help people with suspected upper gastrointestinal bleeding get better results compared to the usual method of waiting for a colonoscopy.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment70 (estimated)
SponsorUniversity of Alberta
Academic / other
Drugs / interventionsradiation
Locations1 site (Edmonton, Alberta)
StatusRecruiting
StartedSeptember 1, 2021
Main results expectedNovember 30, 2026
Study endsNovember 30, 2026
Registry record updatedMarch 16, 2026
Trial IDNCT05108844 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older experiencing new onset acute gastrointestinal bleeding with a negative gastroscopy.

Probably not a fit

Patients who may not benefit include those with prior small bowel surgery, Crohn's disease, strictures, or those unable to provide consent.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of early video capsule endoscopy (VCE) in patients with suspected upper gastrointestinal bleeding (UGIB) who have had a negative gastroscopy. The research compares patient outcomes between those receiving VCE immediately after gastroscopy and those undergoing the standard approach of colonoscopy prior to small bowel investigations. Key metrics such as diagnostic yield, number of procedures, length of hospitalization, mortality rates, and healthcare costs will be analyzed to determine the benefits of this approach.

Why it matters

Potential benefit: If successful, this approach could lead to improved diagnostic accuracy and reduced healthcare costs for patients with upper gastrointestinal bleeding.

How similar studies have gone: While the approach of using early VCE is innovative, similar studies have not been widely conducted, making this a potentially novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* New onset of acute gastrointestinal bleeding defined as:

  1. The presence of melena/maroon stool on physical exam OR history of melena/maroon stool within 48 hours of emergency room presentation PLUS
  2. Hemoglobin drop of ≥ 20 g/L from patient's baseline
* Have capacity to consent
* Hemodynamically stable (i.e. blood pressure \>100/60 or pulse \<110 at the time of consent)
* Initial gastroscopy negative for active bleeding or potential bleeding source

Exclusion Criteria:

* Inability to provide consent due to lack of capacity, language barrier or other reasons
* Pregnant women
* Prior history of small bowel surgery
* Prior history of Crohn's disease
* Prior history of small bowel or colonic strictures
* Prior history of abdominal radiation

Where it's running

  • University of Alberta Hospital
    Edmonton, Alberta, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.